| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 103 / 278 | 63rd | Q2 |
| Oncology | 162 / 428 | 62nd | Q2 |
Expert Review of Anticancer Therapy
ISSN 1473-7140 · 1744-8328
Publisher: Taylor and Francis Ltd.
Is Expert Review of Anticancer Therapy indexed in Scopus? Yes — actively indexed in Scopus, coverage 2001–present, best quartile Q2, CiteScore 4.9.
What is the impact factor of Expert Review of Anticancer Therapy? Expert Review of Anticancer Therapy is indexed in the Science Citation Index Expanded, so Clarivate publishes a Journal Impact Factor for it in the Journal Citation Reports. JCR is a paid Clarivate product, so the JIF value is not free to republish. Its closest free equivalent is the Scopus CiteScore 4.9, which places it in quartile Q2 at the 63rd percentile of its subject.
Is Expert Review of Anticancer Therapy in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Expert Review of Anticancer Therapy open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
Cost to publish: No APC data — check the publisher
Official sources & links
Related journals
- Expert Review of Cardiovascular Therapy
- Expert Review of Clinical Immunology
- Expert Review of Clinical Pharmacology
- Expert Review of Endocrinology and Metabolism
- Expert Review of Gastroenterology and Hepatology
- Expert Review of Hematology
- Expert Review of Medical Devices
- Expert Review of Molecular Diagnostics
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.